The mGluR5 antagonist fenobam induces analgesic conditioned place preference in mice with spared nerve injury

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Lax, Neil C ^a   George, David C ^a   Ignatz, Christopher ^a   Kolber, Benedict J ^a  

^a DUQUESNE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; FENOBAM; METABOTROPIC RECEPTOR 5; MORPHINE SULFATE; 6-METHYL-2-(PHENYLETHYNYL)PYRIDINE; AMINO ACID RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; GRM5 PROTEIN, MOUSE; IMIDAZOLE DERIVATIVE; MORPHINE; PYRIDINE DERIVATIVE;

ANALGESIC ACTIVITY; ANALGESIC CONDITIONED PLACE PREFERENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC PAIN; CONDITIONED PLACE PREFERENCE TEST; CONTROLLED STUDY; DISTRESS SYNDROME; DRUG EFFECT; DRUG TOLERANCE; EXPERIMENTAL COGNITIVE TEST; EXPERIMENTAL SCIATIC NERVE INJURY; FEMALE; LOCOMOTION; MALE; MOUSE; NERVE INJURY; NONHUMAN; PLACE PREFERENCE; SEX DIFFERENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CONDITIONED REFLEX; DRUG EFFECTS; PATHOPHYSIOLOGY; PERIPHERAL NERVE INJURY;

ANALGESICS; ANIMALS; CONDITIONING, CLASSICAL; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; IMIDAZOLES; MALE; MICE; MICE, INBRED C57BL; MORPHINE; PERIPHERAL NERVE INJURIES; PYRIDINES; RECEPTOR, METABOTROPIC GLUTAMATE 5;

EID: 84904908872     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103524     Document Type: Article

References (53)

1. Butler AS, Randall D, Xi J, Bowman V, Cox TL, et al. (2011) Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research. Institute of Medicine of the National Academies.
2. Ingham JM, Portenoy RK (1993) Drugs in the treatment of pain: NSAIDS and opioids. Current Opinion in Anaesthesiology 6: 838-844.
3. Ng SC, Chan FKL (2010) NSAID-induced gastrointestinal and cardiovascular injury. Current Opinion in Gastroenterology 26: 611-617.
4. Benyamin R, Trescot AM, Datta S, Buenaventura R (2008) Opioid complications and side effects. Pain physician 11: S105-120. (Pubitemid 351682081)
5. Fries S, Grosser T, Price TS, Lawson JA, Kapoor S, et al. (2006) Marked Interindividual Variability in the Response to Selective Inhibitors of Cyclooxygenase-2. Gastroenterology 130: 55-64. (Pubitemid 43049835)
6. Shigemoto R NS, Ohishi H, Sugihara H, Nakanishi S, Mizuno N (1993) Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett 163: 53-57. (Pubitemid 23349393)
7. Neugebauer V, Li W, Bird GC, Han JS (2004) The Amygdala and Persistent Pain. The Neuroscientist 10: 221-234. (Pubitemid 38678530)
8. Valerio A, Paterlini M, Boifava M, Memo M, Spano P (1997) Metabotropic glutamate receptor mRNA expression in rat spinal cord. Neuroreport 8: 2695-2699. (Pubitemid 27373515)
9. Kolber BJ, Montana MC, Carrasquillo Y, Xu J, Heinemann SF, et al. (2010) Activation of metabotropic glutamate receptor 5 in the amygdala modulates pain-like behavior. J Neurosci 30: 8203-8213.
10. Fisher K, Coderre TJ (1996) Comparison of nociceptive effects produced by intrathecal administration of mGluR agonists. Neuroreport 7: 2743-2747. (Pubitemid 26403052)
11. Porter RHP, Jaeschke G, Spooren W, Ballard TM, Büttelmann B, et al. (2005) Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity. Journal of Pharmacology and Experimental Therapeutics 315: 711-721. (Pubitemid 41500737)
12. Montana MC, Cavallone LF, Stubbert KK, Stefanescu AD, Kharasch ED, et al. (2009) The Metabotropic Glutamate Receptor Subtype 5 Antagonist Fenobam Is Analgesic and Has Improved in Vivo Selectivity Compared with the Prototypical Antagonist 2-Methyl-6-(phenylethynyl)-pyridine. Journal of Pharmacology and Experimental Therapeutics 330: 834-843.
13. Montana MC, Conrardy BA, Cavallone LF, Kolber BJ, Rao LK, et al. (2011) Metabotropic Glutamate Receptor 5 Antagonism with Fenobam: Examination of Analgesic Tolerance and Side Effect Profile in Mice. Anesthesiology 115: 1239-1250 1210.1097/ALN.1230b1013e318238c318051.
14. Mogil JS (2012) Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon. Nat Rev Neurosci 13: 859-866.
15. Craft RM, Mogil JS, Maria Aloisi A (2004) Sex differences in pain and analgesia: the role of gonadal hormones. European Journal of Pain 8: 397-411. (Pubitemid 39485765)
16. Paller CJ, Campbell CM, Edwards RR, Dobs AS (2009) Sex-Based Differences in Pain Perception and Treatment. Pain Medicine 10: 289-299.
17. Richner M, Bjerrum OJ, Nykjaer A, Vaegter CB (2011) The Spared Nerve Injury (SNI) Model of Induced Mechanical Allodynia in Mice. e3092.
18. Bourquin A-F, Süveges M, Pertin M, Gilliard N, Sardy S, et al. (2006) Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse. PAIN 122.
19. Decosterd I, Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87: 149-158. (Pubitemid 30621447)
20. Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Progress in Neurobiology 56: 613-672.
21. King T, Vera-Portocarrero L, Gutierrez T, Vanderah TW, Dussor G, et al. (2009) Unmasking the tonic-aversive state in neuropathic pain. Nat Neurosci 12: 1364-1366.
22. He Y, Tian X, Hu X, Porreca F, Wang ZJ (2012) Negative Reinforcement Reveals Non-Evoked Ongoing Pain in Mice With Tissue or Nerve Injury. The journal of pain : official journal of the American Pain Society 13: 598-607.
23. Tryba M, Gehling M (2002) Clonidine-a potent analgesic adjuvant. Curr Opin Anaesthesiol 15: 511-517.
24. Xia Z, Chen Y, Zhu Y, Wang F, Xu X, et al. (2006) Recombinant omega-conotoxin MVIIA possesses strong analgesic activity. BioDrugs 20: 275-281. (Pubitemid 44556051)
25. Corbett AD, Henderson G, McKnight AT, Paterson SJ (2006) 75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharmacol 147 Suppl 1: S153-162. (Pubitemid 43077273)
26. Crock LW, Stemler KM, Song DG, Abbosh P, Vogt SK, et al. (2012) Metabotropic glutamate receptor 5 (mGluR5) regulates bladder nociception. Mol Pain 8: 20.
27. Ruiu S, Longoni R, Spina L, Orru A, Cottiglia F, et al. (2013) Withania somnifera prevents acquisition and expression of morphine-elicited conditioned place preference. Behav Pharmacol 24: 133-143.
28. Mattioli L, Titomanlio F, Perfumi M (2012) Effects of a Rhodiola rosea L. extract on the acquisition, expression, extinction, and reinstatement of morphine-induced conditioned place preference in mice. Psychopharmacology (Berl) 221: 183-193.
29. Pecknold JC, McClure DJ, Appeltauer L, Wrezesinski L, Allan T (1982) Treatment of Anxiety Using Fenobam (a Nonbenzodiazepine) in a Double-Blind Standard Placebo-Controlled Study. J Clin Pharmacol 2: 129-133. (Pubitemid 12025672)
30. Friedmann C, Davis L, Ciccone P, Rubin R (1980) Phase II double blind controlled study of a new anxiolytic, fenobam (McN-3377) vs placebo. Curr Ther Res 27: 144-151. (Pubitemid 10149548)
31. Chiechio S, Nicoletti F (2012) Metabotropic glutamate receptors and the control of chronic pain. Current Opinion in Pharmacology 12: 28-34.
32. Zhu CZ, Hsieh G, Ei-Kouhen O, Wilson SG, Mikusa JP, et al. (2005) Role of central and peripheral mGluR5 receptors in post-operative pain in rats. Pain 114: 195-202. (Pubitemid 40279101)
33. Bhave G, Carlton SM, Gereau Iv RW, Karim F (2001) Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nature Neuroscience 4: 417+.
34. Jia H, Rustioni A, Valtschanoff JG (1999) Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn. The Journal of Comparative Neurology 410: 627-642. (Pubitemid 29316073)
35. Li W, Neugebauer V (2004) Differential Roles of mGluR1 and mGluR5 in Brief and Prolonged Nociceptive Processing in Central Amygdala Neurons. Journal of Neurophysiology 91: 13-24. (Pubitemid 38084349)
36. Crock LW, Kolber BJ, Morgan CD, Sadler KE, Vogt SK, et al. (2012) Central Amygdala Metabotropic Glutamate Receptor 5 in the Modulation of Visceral Pain. The Journal of Neuroscience 32: 14217-14226.
37. Kalliomaki J, Huizar K, Kagedal M, Hagglof B, Schmelz M (2013) Evaluation of the effects of a metabotropic glutamate receptor 5-antagonist on electrically induced pain and central sensitization in healthy human volunteers. Eur J Pain 17: 1465-1471.
38. Osikowicz M, Mika J, Makuch W, Przewlocka B (2008) Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain. PAIN 139: 117-126.
39. Blackburn-Munro G (2004) Pain-like behaviours in animals - how human are they? Trends in Pharmacological Sciences 25: 299-305.
40. Woller SA, Moreno GL, Hart N, Wellman PJ, Grau JW, et al. (2012) Analgesia or addiction?: implications for morphine use after spinal cord injury. J Neurotrauma 29: 1650-1662.
41. Yu F, Zhong P, Liu X, Sun D, Gao HQ, et al. (2013) Metabotropic glutamate receptor I (mGluR1) antagonism impairs cocaine-induced conditioned place preference via inhibition of protein synthesis. Neuropsychopharmacology 38: 1308-1321.
42. Herrold AA, Voigt RM, Napier TC (2013) mGluR5 is necessary for maintenance of methamphetamine-induced associative learning. European Neuropsychopharmacology 23: 691-696.
43. Popik P, Wrobel M (2002) Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology 43: 1210-1217. (Pubitemid 36084432)
44. Munce SE, Stewart DE (2007) Gender differences in depression and chronic pain conditions in a national epidemiologic survey. Psychosomatics 48: 394-399. (Pubitemid 47330291)
45. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38: 19-28.
46. Clemens JQ, Meenan RT, Rosetti MCOK, Gao SY, Calhoun EA (2005) Prevalence and incidence of interstitial cystitis in a managed care population. The Journal of Urology 173: 98-102. (Pubitemid 39627682)
47. Beery AK, Zucker I (2011) Sex bias in neuroscience and biomedical research. Neuroscience & Biobehavioral Reviews 35: 565-572.
48. Bair MJ, Robinson RL, Katon W, Kroenke K (2003) Depression and pain comorbidity: A literature review. Archives of Internal Medicine 163: 2433-2445. (Pubitemid 37385786)
49. Mutso AA, Radzicki D, Baliki MN, Huang L, Banisadr G, et al. (2012) Abnormalities in Hippocampal Functioning with Persistent Pain. The Journal of Neuroscience 32: 5747-5756.
50. Gonçalves L, Silva R, Pinto-Ribeiro F, Pêgo JM, Bessa JM, et al. (2008) Neuropathic pain is associated with depressive behaviour and induces neuroplasticity in the amygdala of the rat. Experimental Neurology 213: 48-56.
51. Reid LD, Marglin SH, Mattie ME, Hubbell CL (1989) Measuring morphine's capacity to establish a place preference. Pharmacology Biochemistry and Behavior 33: 765-775. (Pubitemid 19284286)
52. Vindenes V, Handal M, Ripel Å, Boix F, Mørland J (2006) Conditioned place preference induced by morphine and morphine-6-glucuronide in mice. Pharmacology Biochemistry and Behavior 85: 292-297. (Pubitemid 44895551)
53. Mohammed W, Alhaddad H, Marie N, Tardy F, Lamballais F, et al. (2013) Comparison of tolerance to morphine-induced respiratory and analgesic effects in mice. Toxicology Letters 217: 251-259.